Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.

[1]  F. Chang,et al.  Determination of the optimal model for end‐stage liver disease score in patients with small hepatocellular carcinoma undergoing loco‐regional therapy , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  Adnan Said,et al.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. , 2004, Journal of hepatology.

[3]  D. V. van Thiel,et al.  The development of de novo hepatocellular carcinoma in patients on a liver transplant list: Frequency, size, and assessment of current screening methods , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  R. Wiesner,et al.  Improving liver allocation: MELD and PELD , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  S. Saab,et al.  Liver transplantation in the era of model for end‐stage liver disease , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[6]  A. Mihas,et al.  Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. , 2003, Gastroenterology.

[7]  R. Testa,et al.  Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. , 2003, Gastroenterology.

[8]  R. Testa,et al.  Trans‐catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End‐stage Liver Disease (MELD), in predicting outcome after treatment , 2003, Alimentary pharmacology & therapeutics.

[9]  M Peck-Radosavljevic,et al.  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt , 2003, Gut.

[10]  Rolf Fimmers,et al.  Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting , 2003, American Journal of Gastroenterology.

[11]  R. Moreau,et al.  Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD , 2003, Hepatology.

[12]  E Testa,et al.  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study , 2003, Gut.

[13]  R. Wolfe,et al.  Longitudinal assessment of mortality risk among candidates for liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  W. Kim,et al.  Is the change in MELD score a better indicator of mortality than baseline MELD score? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  V. Arroyo,et al.  Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. , 2002, Gastroenterology.

[16]  A. Nicolini,et al.  MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. , 2002, Journal of hepatology.

[17]  Eric B. Edwards,et al.  MELD and PELD: Application of survival models to liver allocation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  G. Bynum,et al.  Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. , 2001 .

[19]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[20]  R. Wiesner,et al.  Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  L. Goldman,et al.  A prognostic model for patients with end-stage liver disease. , 1997, Gastroenterology.

[22]  C. Bartolozzi,et al.  Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 western patients , 1995, Cancer.

[23]  D. Collett.  Modelling Survival Data in Medical Research , 1994 .

[24]  K. Chayama,et al.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.

[25]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[28]  S. Sherlock,et al.  Diseases of the Liver and Biliary System , 1955 .

[29]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[30]  S. D. Lee,et al.  Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. , 2003, Scandinavian journal of gastroenterology.

[31]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.